Study of Safety and Pharmacokinetics of MK-8242 in Participants With Advanced Solid Tumors (P07650)
NCT01463696
·
clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
48
Enrollment
INDUSTRY
Sponsor class
Conditions
Solid Tumors
Interventions
DRUG:
MK-8242
Sponsor
Merck Sharp & Dohme LLC